HDV RNA assays: Performance characteristics, clinical utility, and challenges

Coinfection with HBV and HDV results in hepatitis D, the most severe form of chronic viral hepatitis, frequently leading to liver decompensation and HCC. Pegylated interferon alpha, the only treatment option for chronic hepatitis D for many years, has limited efficacy. New treatments are in advanced...

Full description

Bibliographic Details

Published in:	Hepatology (Baltimore, Md.) Vol. 81; no. 2; pp. 637 - 650
Main Authors:	Wedemeyer, Heiner, Leus, Mitchell, Battersby, Thomas R., Glenn, Jeffrey, Gordien, Emmanuel, Kamili, Saleem, Kapoor, Hema, Kessler, Harald H., Lenz, Oliver, Lütgehetmann, Marc, Mixson-Hayden, Tonya, Simon, Christian O., Thomson, Michael, Westman, Gabriel, Miller, Veronica, Terrault, Norah, Lampertico, Pietro
Format:	Journal Article
Language:	English
Published:	United States Lippincott Williams & Wilkins 01.02.2025
Subjects:	Antiviral Agents - therapeutic use Coinfection Hepatitis D - diagnosis Hepatitis D - drug therapy Hepatitis D - virology Hepatitis D, Chronic - diagnosis Hepatitis D, Chronic - drug therapy Hepatitis D, Chronic - virology Hepatitis Delta Virus - genetics Hepatitis Delta Virus - isolation & purification Humans Reviews RNA, Viral - analysis
ISSN:	0270-9139, 1527-3350, 1527-3350
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!